Loading...
XHKG
1696
Market cap252mUSD
Dec 05, Last price  
4.20HKD
1D
-0.47%
1Q
-28.45%
IPO
-52.81%
Name

Sisram Medical Ltd

Chart & Performance

D1W1MN
XHKG:1696 chart
P/E
10.06
P/S
0.72
EPS
0.05
Div Yield, %
3.76%
Shrs. gr., 5y
1.16%
Rev. gr., 5y
15.01%
Revenues
349m
-2.83%
101,321,000110,406,000118,156,000136,887,000153,919,000173,520,000162,095,000294,294,000354,480,000359,292,000349,112,000
Net income
25m
-20.23%
5,943,0007,814,0008,055,00011,049,00021,831,00020,785,00013,344,00031,245,00040,170,00031,499,00025,126,000
CFO
33m
-24.70%
22,807,00015,847,00016,013,00017,057,00016,236,00021,037,00025,737,00032,377,00022,039,00043,936,00033,083,000
Dividend
Aug 26, 20240.158 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Sisram Medical Ltd, an investment holding company, designs, develops, manufactures, and sells energy-based aesthetic medical, minimally invasive treatment systems, and non-energy based devices and cosmeceuticals in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. It offers products and treatments portfolio, including hair removal, skin rejuvenation, acne and acne scars, body and face contouring, pigmentation and skin resurfacing, fat grafting, dermal facial fillers, skin tissue remodelling injectables, personal care, aesthetic dentistry, trans epidermal delivery, cellulite treatment, stretch marks, vascular and pigmented lesions, hydradermabrasion, blepharoplasty-non surgical eyelid lift, liposuction, feminine health, and sexual rehabilitation. The company manufactures, distributes, and sells medical equipment. It offers its products under the Alma, Soprano, Harmony, Copulla, Foshion, Accent, and LMNT brands. Sisram Medical Ltd was incorporated in 2013 and is headquartered in Caesarea, Israel.
IPO date
Sep 19, 2017
Employees
1,102
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT